189 related articles for article (PubMed ID: 38001629)
1. A Radiomics Approach to Identify Immunologically Active Tumor in Patients with Head and Neck Squamous Cell Carcinomas.
Nguyen TM; Bertolus C; Giraud P; Burgun A; Saintigny P; Bibault JE; Foy JP
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001629
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes.
Huang C; Cintra M; Brennan K; Zhou M; Colevas AD; Fischbein N; Zhu S; Gevaert O
EBioMedicine; 2019 Jul; 45():70-80. PubMed ID: 31255659
[TBL] [Abstract][Full Text] [Related]
3. Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients.
Foy JP; Karabajakian A; Ortiz-Cuaran S; Boussageon M; Michon L; Bouaoud J; Fekiri D; Robert M; Baffert KA; Hervé G; Quilhot P; Attignon V; Girod A; Chaine A; Benassarou M; Zrounba P; Caux C; Ghiringhelli F; Lantuejoul S; Crozes C; Brochériou I; Pérol M; Fayette J; Bertolus C; Saintigny P
Eur J Cancer; 2022 Oct; 174():287-298. PubMed ID: 36038492
[TBL] [Abstract][Full Text] [Related]
4. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
5. Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma.
Katsoulakis E; Yu Y; Apte AP; Leeman JE; Katabi N; Morris L; Deasy JO; Chan TA; Lee NY; Riaz N; Hatzoglou V; Oh JH
Oral Oncol; 2020 Nov; 110():104877. PubMed ID: 32619927
[TBL] [Abstract][Full Text] [Related]
6. Site-Specific Variation in Radiomic Features of Head and Neck Squamous Cell Carcinoma and Its Impact on Machine Learning Models.
Liu X; Maleki F; Muthukrishnan N; Ovens K; Huang SH; Pérez-Lara A; Romero-Sanchez G; Bhatnagar SR; Chatterjee A; Pusztaszeri MP; Spatz A; Batist G; Payabvash S; Haider SP; Mahajan A; Reinhold C; Forghani B; O'Sullivan B; Yu E; Forghani R
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359623
[TBL] [Abstract][Full Text] [Related]
7. Improving radiomic model reliability using robust features from perturbations for head-and-neck carcinoma.
Teng X; Zhang J; Ma Z; Zhang Y; Lam S; Li W; Xiao H; Li T; Li B; Zhou T; Ren G; Lee FK; Au KH; Lee VH; Chang ATY; Cai J
Front Oncol; 2022; 12():974467. PubMed ID: 36313629
[TBL] [Abstract][Full Text] [Related]
8. Utility of adding Radiomics to clinical features in predicting the outcomes of radiotherapy for head and neck cancer using machine learning.
Gangil T; Sharan K; Rao BD; Palanisamy K; Chakrabarti B; Kadavigere R
PLoS One; 2022; 17(12):e0277168. PubMed ID: 36520945
[TBL] [Abstract][Full Text] [Related]
9. Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive.
Zhu Y; Mohamed ASR; Lai SY; Yang S; Kanwar A; Wei L; Kamal M; Sengupta S; Elhalawani H; Skinner H; Mackin DS; Shiao J; Messer J; Wong A; Ding Y; Zhang L; Court L; Ji Y; Fuller CD
JCO Clin Cancer Inform; 2019 Feb; 3():1-9. PubMed ID: 30730765
[TBL] [Abstract][Full Text] [Related]
10. Radiomics combined with transcriptomics to predict response to immunotherapy from patients treated with PD-1/PD-L1 inhibitors for advanced NSCLC.
Bouhamama A; Leporq B; Faraz K; Foy JP; Boussageon M; Pérol M; Ortiz-Cuaran S; Ghiringhelli F; Saintigny P; Beuf O; Pilleul F
Front Radiol; 2023; 3():1168448. PubMed ID: 37492391
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a CECT-based radiomics model for predicting IL1B expression and prognosis of head and neck squamous cell carcinoma.
Xie Y; Wang M; Xia H; Sun H; Yuan Y; Jia J; Chen L
Front Oncol; 2023; 13():1121485. PubMed ID: 36969073
[TBL] [Abstract][Full Text] [Related]
12. CT-based Radiomic Signatures for Predicting Histopathologic Features in Head and Neck Squamous Cell Carcinoma.
Mukherjee P; Cintra M; Huang C; Zhou M; Zhu S; Colevas AD; Fischbein N; Gevaert O
Radiol Imaging Cancer; 2020 May; 2(3):e190039. PubMed ID: 32550599
[TBL] [Abstract][Full Text] [Related]
13. A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study.
Corino VDA; Bologna M; Calareso G; Licitra L; Ghi M; Rinaldi G; Caponigro F; Morelli F; Airoldi M; Allegrini G; Cassano A; Ferrari D; Mirabile A; Tosoni A; Galizia D; Merlano M; Sponghini A; Moretti G; Mainardi L; Bossi P
Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34071518
[TBL] [Abstract][Full Text] [Related]
14. Non-Contrasted CT Radiomics for SAH Prognosis Prediction.
Shan D; Wang J; Qi P; Lu J; Wang D
Bioengineering (Basel); 2023 Aug; 10(8):. PubMed ID: 37627852
[TBL] [Abstract][Full Text] [Related]
15. Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.
Bogowicz M; Riesterer O; Ikenberg K; Stieb S; Moch H; Studer G; Guckenberger M; Tanadini-Lang S
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):921-928. PubMed ID: 28807534
[TBL] [Abstract][Full Text] [Related]
16. Framework for Machine Learning of CT and PET Radiomics to Predict Local Failure after Radiotherapy in Locally Advanced Head and Neck Cancers.
Devakumar D; Sunny G; Sasidharan BK; Bowen SR; Nadaraj A; Jeyseelan L; Mathew M; Irodi A; Isiah R; Pavamani S; John S; T Thomas HM
J Med Phys; 2021; 46(3):181-188. PubMed ID: 34703102
[TBL] [Abstract][Full Text] [Related]
17. A computed tomography-based radiomics signature for predicting expression of programmed death ligand 1 in head and neck squamous cell carcinoma.
Zheng YM; Yuan MG; Zhou RQ; Hou F; Zhan JF; Liu ND; Hao DP; Dong C
Eur Radiol; 2022 Aug; 32(8):5362-5370. PubMed ID: 35298679
[TBL] [Abstract][Full Text] [Related]
18. Preliminary Computed Tomography Radiomics Model for Predicting Pretreatment CD8+ T-Cell Infiltration Status for Primary Head and Neck Squamous Cell Carcinoma.
Wang CY; Ginat DT
J Comput Assist Tomogr; 2021 Jul-Aug 01; 45(4):629-636. PubMed ID: 34519454
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced CT-based radiomic analysis for determining the response to anti-programmed death-1 therapy in esophageal squamous cell carcinoma patients: A pilot study.
Yang Q; Huang H; Zhang G; Weng N; Ou Z; Sun M; Luo H; Zhou X; Gao Y; Wu X
Thorac Cancer; 2023 Nov; 14(33):3266-3274. PubMed ID: 37743537
[TBL] [Abstract][Full Text] [Related]
20. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
Keek S; Sanduleanu S; Wesseling F; de Roest R; van den Brekel M; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P
PLoS One; 2020; 15(5):e0232639. PubMed ID: 32442178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
